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Abstract Haemophilus influenzae lipoprotein e (P4) is a
member of the DDDD phosphohydrolase superfamily and
mediates heme transport. Each of the aspartate residues of the
signature motif is required for phosphomonoesterase activity, as
none of the e (P4) single D mutants (D64A, D66A, D181N, and
D185A) possessed detectable phosphomonoesterase activity.
These results suggest that the signature motif is essential to the
phosphomonoesterase activity of lipoprotein e (P4). When
assessed for phosphomonoesterase-dependent heme transport
activity in Escherichia coli hemA strains, plasmids containing
D181N and D185A retained heme transport as indicated by
aerobic growth while D64A and D66A did not. We conclude
that phosphomonoesterase activity is not required for heme
transport. ß 2001 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
Haemophilus in£uenzae is a Gram-negative coccobacillus, a
common commensal and occasional pathogen of the human
respiratory tract ; it requires both heme and nicotinamide ad-
enine disnucleotide (NAD) for aerobic growth [1]. Macromo-
lecules in the outer membrane of this organism not only di-
rectly mediate interactions at the host^pathogen interface, but
are also essential for acquisition and transport of requisite
nutrients and cofactors including heme and NAD. The outer
membrane of H. in£uenzae possesses up to 36 proteins [2] of
which six, designated P1^P6, represent major protein constit-
uents [3]. While interest in these major proteins has been for
potential vaccine components, their biological role is only
beginning to be determined.
H. in£uenzae lipoprotein e (P4) is one outer membrane pro-
tein to which important physiological roles have been as-
signed. This surface-localized 28-kDa lipoprotein is found in
all strains of H. in£uenzae, is encoded by the hel gene and is
antigenically conserved within and between strains [4]. In sep-
arate studies, e (P4) was found to mediate the transport of
both heme [5] and nicotinamide nucleotides [6] into this heme
and NAD-requiring organism. Lipoprotein e (P4) was initially
puri¢ed as a potential component of a non-typeable H. in£u-
enzae vaccine [4]. Our laboratory puri¢ed, characterized the
protein as an acid phosphatase [7] and produced a soluble
recombinant form of the enzyme [8].
Bacterial non-speci¢c acid phosphatases (NSAPs) are found
as soluble enzymes associated with the periplasmic space or as
constituents of the bacterial membrane. They generally have
broad substrate speci¢city and have optimum activity at acidic
to neutral pH. Results from biochemical characterization of
the enzymes and amino acid relatedness suggest that NSAPs
constitute three distinct classes of enzymes designated A, B, or
C [9]. Results from amino acid sequence alignment [10], its
identi¢cation as a bacterial lipoprotein [4], and enzymatic
characterization [7] suggest that H. in£uenzae lipoprotein e
(P4) belongs to NSAP class C [9]. These enzymes, along
with those of class B and related plant phosphatases belong
to an enzyme superfamily designated DDDD phosphohydro-
lases, so named for the presence of two pairs of requisite
aspartic acid residues present in separate domains of the pro-
teins and separated by a variable spacer region [9].
While sequence alignments suggest these aspartic acid resi-
dues are essential for enzymatic activity of the bacterial non-
speci¢c acid phosphatases in this superfamily, direct demon-
stration of their importance has not been reported. The pur-
pose of the present study was two-fold: (1) to determine
whether each of the aspartic acid residues of the DDDD sig-
nature motif is required for enzymatic activity of e (P4) and
(2) to determine if phosphomonoesterase activity of H. in£u-
enzae lipoprotein e (P4) was necessary for one of the protein’s
physiological roles, heme transport. Site-directed mutants
were constructed at each of the four aspartic acid residues,
sequenced and assessed for enzymatic activity as well as pres-
ence of the e (P4) antigen. An aspartate presumed to be irrel-
evant, D49 was also changed to an alanine to control for the
loss of the carboxylate on the overall pI of the enzyme. Plas-
mids containing wild-type or mutant hel genes were trans-
formed into hemA strains of Escherichia coli and assessed
for their ability to mediate heme transport indicated by aero-
bic growth.
2. Materials and methods
2.1. Bacteria and growth conditions
E. coli strains RK1065 (F, leu, pro, hemA) and SASX77 (lacY1,
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glnV44, hem48, trpA43, rpsL134(strR), malT1(VR), metB1) were ob-
tained from Dr. Robert Kadner (University of Virginia) and the E.
coli Genetic Stock Center respectively and grown in the presence of
aminolevulinic acid unless otherwise indicated. E. coli strain DH5K
used for plasmid manipulation and ampli¢cation was obtained from
BRL. E. coli transformants were grown at 37‡C on LB agar or in
broth containing the appropriate antibiotic (chloramphenicol 34
Wg/ml or ampicillin 100 Wg/ml) prior to assessment of phosphomo-
noesterase activity, or identi¢cation of wild-type or mutant lipopro-
tein e (P4) antigen by Western blot analysis. E. coli transformants
containing wild-type or mutant forms of the hel gene in pBluescript
were also screened on tryptose phosphate (Difco Laboratories) methyl
green indicator media containing phenolphthalein diphosphate for
assessment of phosphatase activity according to the method of Riccio
et al. [11].
2.2. Determination of speci¢c phosphomonoesterase activity
Speci¢c phosphomonoesterase activity of transformed E. coli strains
was measured using a discontinuous colorimetric assay in microtiter
wells as described previously [7]. The 0.2-ml standard assay mixture
contained 0.2 M sodium acetate, pH 5.5, 0.1 mM CuSO4, 1.0 mM
p-nitrophenylphosphate (pNPP), and varying amounts of sample. The
mixtures were incubated at 37‡C for 15 min with constant agitation.
The reaction was stopped by addition of 100 Wl 0.5 M glycine, pH
10.0. Concentration of p-nitrophenol produced was measured with a
Dynatech MR5000 microtiter plate reader at 410 nm using an extinc-
tion coe⁄cient of 18.3 mM31 cm31. Enzyme preparations were di-
luted in 50 mM sodium acetate pH 6.0 containing 200 mM NaCl to a
concentration that resulted in a linear response with increasing
amounts of sample. One unit of enzyme activity was de¢ned as the
amount of activity required to convert 1 nmol substrate to product
per hour at 37‡C. Protein concentrations were determined using bi-
cinchoninic acid (BCA protein assay reagent, Pierce) as described
previously [12]. Bovine serum albumin was used as the standard.
2.3. Construction of lipoprotein e (P4) phosphomonoesterase mutants
The wild-type hel gene was cloned into the BamHI site of pBlue-
script and designated phel3 [7], and was used as the template for
PCR-mediated mutagenesis. Site-directed mutations were generated
using the QuickChange site-directed mutagenesis kit according to
the manufacturer’s (Stratagene) instructions. The following oligonu-
cleotide PCR primers and their reverse complement (not shown) were
synthesized at the University of Missouri DNA Core. Degenerate






The mutagenesis primers were coincubated with plasmid phel3
through 16 cycles of PCR ampli¢cation. One cycle consisted of the
following three steps: (i) 30 s at 95‡C, (ii) 1 min at 55‡C, and (iii) 9
min at 68‡C. PCR-generated replicons were selected for transforma-
tion by 60 min incubation with the restriction enzyme DpnI. Plasmids
containing mutated hel genes were transformed into E. coli DH5K by
the heat-shock method. Transformants obtained after overnight incu-
bation on LB agar containing ampicillin (100 Wg/ml) were screened for
the presence of phosphomonoesterase activity by the phenolphthalein
diphosphate methyl green assay. Plasmids were isolated from those
clones devoid of activity using Promega Wizard Plus miniprep kit.
The presence of the desired mutation was con¢rmed by DNA se-
quencing. Wild-type and mutant hel genes were then cloned into the
EcoRV/XbaI site of pACYC184, transformed into E. coli DH5K, and
grown on LB agar containing chloramphenicol (34 Wg/ml). Plasmid
DNA was isolated from individual clones as previously described,
transformed into E. coli strains RK1065 and SASX77B and grown
on LB agar containing chloramphenicol (34 Wg/ml) and aminolevu-
linic acid (25 Wg/ml). Heme transport activity by wild-type and mutant
lipoprotein e (P4) in E. coli hemA strains was assessed by aerobic
incubation at 37‡C on LB agar containing chloramphenicol 34
Wg/ml and heme (equine hemin HCl, Sigma) 15 Wg/ml.
2.4. Polyacrylamide gel electrophoresis and detection of lipoprotein e
(P4) by Western blot
Sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) was performed as described by Laemmli [13]. Polyacrylamide
gels were 3% T stacking and 11% T resolving. Western blot detection
of e (P4) was performed as described previously [14]. Puri¢ed mouse
anti-H. in£uenzae e (P4) monoclonal antibody EPR5-2.1 was used as
the primary antibody (1:10 000 dilution) and rabbit anti-mouse IgG
(heavy and light chain; Sigma) conjugated to alkaline phosphatase
was used as the secondary antibody (1:10 000 dilution).
3. Results
To determine if the conserved aspartic acid residues of the
DDDD phosphomonoesterase motif, D64, D66, D181, and
D185 in lipoprotein e (P4) are necessary for phosphatase ac-
tivity and for heme transport activity, mutations in the hel
gene were generated at each of these positions. Site-directed
mutagenesis of the hel gene resulted in the following substitu-
tions: D64A, D66A, D181N, and D185A. Overnight cultures
of E. coli strain DH5K transformed with plasmids bearing
mutated hel genes possessed speci¢c phosphatase activity
equal to that seen with the control transformant containing
pBluescript. When incubated overnight at 37‡C on tryptose
phosphate agar containing phenolphthalein diphosphate (1
mg/ml), methyl green (50 Wg/ml), and ampicillin (100 Wg/ml)
only transformants harboring the wt hel gene produced green-
stained colonies indicative of an active phosphomonoesterase
(Fig. 1). When analyzed for speci¢c phosphomonoesterase
activity using the discontinuous colorimetric assay, E. coli
transformed with hel gene mutants possessed enzyme activity
at approximately 10% of the level of activity as an E. coli
strain transformed with a plasmid bearing wt hel (Fig. 2).
Reduction in enzymatic activity was not attributed to seques-
Fig. 1. Detection of phosphomonoesterase in E. coli DH5K trans-
formed with pBluescript vector control, phel3 wt, or phel3 mutants
plated on tryptose phosphate methyl green phenolphthalein diphos-
phate indicator media. Phosphatase-producing clones grow as green-
stained colonies whereas phosphatase-negative clones grow as un-
stained colonies. The mutants are F48C, D48A, D66A, D181N and
D185A; wt = wild-type and vector is E. coli DH5K with pBluescript.
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tration of the enzyme as assay of French press lysates of these
strains resulted in no signi¢cant increase in phosphatase ac-
tivity (data not shown). Western blot analysis (Fig. 3) indi-
cated that E. coli containing the wt (lane 3) and each of the
mutants (lanes 4^8) produced similar levels of an V28-kDa
antigen identi¢ed as lipoprotein e (P4) with anti-H. in£uenzae
e (P4) monoclonal antibody EPR5-2.1. Sequence analysis of
the mutated hel genes con¢rmed the presence of the predicted
mutations. Puri¢ed mutant proteins were devoid of detectable
levels of phosphomonoesterase activity in both the discontin-
uous colorimetric assay using pNPP as substrate and when
assessed by zymogram assay conducted on puri¢ed mutant
enzymes as described by Rossolini et al. [15] (and unpublished
results). These data indicate that each of the conserved as-
partic acid residues of the DDDD signature motif of lipopro-
tein e (P4) is required for phosphomonoesterase activity. Not
all aspartic acid residues present in e (P4) were required for
phosphomonoesterase activity as E. coli transformants con-
taining a D49A hel gene have enzyme activity on the indicator
plates (Fig. 1).
To determine if phosphomonoesterase activity was required
for lipoprotein e (P4)-mediated transport of exogenous heme,
wild-type and mutant hel genes were cloned into pACYC184
and transformed into E. coli hemA strains RK1065 and
SASX77B. Both strains are defective in aminolevulinic acid
synthetase, auxotrophic for ALA, and used as reporter strains
for gene products involved in heme transport which is essen-
tial for aerobic growth.
After overnight growth in LB containing chloramphenicol
and aminolevulinic acid, all transformed strains were found to
produce e (P4) by Western blot (data not shown). None of the
transformed strains of RK1065 nor SASX77B containing wt
or a mutant hel gene grew aerobically on LB agar without
ALA; all transformants grew aerobically in its presence (Ta-
ble 1). When tested for their ability to transport exogenous
heme, two of the four plasmids carrying e (P4) D mutants in
hemA strains grew aerobically, indicating that they mediated
transport of heme (Table 1): speci¢cally e (P4) with substitu-
tions D181N and D185A, were able to transport heme. Thus,
phosphomonoesterase activity is not required for heme trans-
port as these mutants were found to lack detectable phospha-
tase activity in both crude and puri¢ed preparations. In con-
trast, neither the D64A nor D66A mutants mediated heme
transport as indicated by lack of aerobic growth of the
hemA strains harboring plasmids with these mutations. The
lack of aerobic growth of the D64 and D66 mutants may
re£ect proximity e¡ects on the putative heme-binding site
(K45^H50) of lipoprotein e (P4).
In conjunction with the above studies, a lipoprotein e (P4)
predicted to be defective in transport of exogenous heme was
Fig. 2. Phosphomonoesterase speci¢c activity of wild-type and mu-
tant e (P4) constructs as measured by the discontinuous enzyme as-
say described in Section 2. Average activity (open bars) of ¢ve inde-
pendent samples for each clone is shown with standard deviation
(error bars) indicated for each.
Fig. 3. Western blot detection of lipoprotein e (P4) antigen with
mouse monoclonal antibody EPR5-2.1. Amersham prestained stan-
dards (lane 1), 25 Wg of E. coli transformants (as indicated) was
loaded in lanes 2^8.
Table 1
Assessment of lipoprotein e (P4) heme transport activity in E. coli
hemA strains
Plasmid LB chlor LB chlor/ALA LB chlor/heme
Strain RK1065
pACYC184 3 + 3
phel22 wt 3 + +
phel22 F48C 3 + 3
phel22 D64A 3 + 3
phel22 D66A 3 + 3
phel22 D181N 3 + +
phel22 D185A 3 + +
Strain SASX77
pACYC184 3 + 3
phel22 wt 3 + +
phel22 F48C 3 + 3
phel22 D64A 3 + 3
phel22 D66A 3 + 3
phel22 D181N 3 + +
phel22 D185A 3 + +
Vector control, wt, or mutant hel genes present on pACYC184 were
transformed into hemA strains of E. coli and plated on LB agar
containing the above constituents and placed at 37‡C for 24 h. Pres-
ence of at least one single well-de¢ned colony is indicated by (+);
no growth is indicated by (3).
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made by creating a mutation in the conserved phenylalanine
residue (F48) of the putative heme-binding site KVAFDH [5].
Incorporated nucleotide changes were predicted to result in
the concomitant creation of a unique SphI site in phel3 and
substitution of F48 with a cysteine residue in e (P4) producing
KVACDH. All transformants analyzed after mutagenesis con-
tained the SphI site and were found to possess the predicted
mutation by DNA sequencing. The F48C transformant was
positive for the 28-kDa antigen as assessed by Western blot
(Fig. 3, lane 4) using monoclonal antibody EPR5-2.1. Inter-
estingly this mutation not only resulted in a mutant incapable
of heme transport in E. coli hemA strains (Table 1) but also
resulted in production of lipoprotein e (P4) devoid of phos-
phomonoesterase activity (Figs. 1 and 2). Mature lipoprotein
e (P4) is devoid of free sulfhydryl groups as its only cysteine
residue is covalently linked to a diacylglyceryl moiety attached
to the N-terminal cysteine of the lipoprotein [4,16]. Replace-
ment of phenylalanine 48 with a cysteine may therefore have
resulted in formation of e (P4) dimers through the formation
of disul¢de bonds between mutant proteins preventing sub-
strate access to the active site. However, the lack of enzymatic
activity could not be attributed to formation of such dimers as
no signi¢cant increase in activity was observed in the presence
of 1 mM mercaptoethanol, a concentration which had no
deleterious e¡ect on the phosphomonoesterase of crude or
puri¢ed e (P4) [7]. These data suggest that while F48 is an
essential component of the heme-binding motif as previously
suggested [5], it is also important for phosphomonoesterase
activity of H. in£uenzae lipoprotein e (P4).
4. Discussion
The goals of this study were to determine the following:
(1) are the four aspartic acid residues of the DDDD phospho-
hydrolase signature motif essential for phosphomonoesterase
activity of lipoprotein e (P4), and (2) is enzymatic activity
necessary for e (P4)-mediated heme transport into E. coli
strains defective in heme biosynthesis.
Identi¢cation as a bacterial lipoprotein [4], presence of the
DDDD signature motif [10], and biochemical characterization
of lipoprotein e (P4) are all consistent with this enzyme’s in-
clusion in this phosphohydrolase superfamily. Results from
this study indicate that the DDDD motif is essential to the
phosphomonoesterase activity of lipoprotein e (P4) and sug-
gest that these residues may be indispensable to the enzymatic
activity of all members of the superfamily. These results are
consistent with those obtained with two other enzymes of the
superfamily [17,18]. Collet et al. have demonstrated that the
¢rst aspartic acid residue of the signature motif present in
other enzymes in the family, a phosphomannomutase [17]
and a phosphoserine phosphatase [18] is essential to catalysis
through formation of a covalent acyl-phosphate intermediate.
The fourth aspartic acid residue of the motif binds magnesi-
um, a requisite divalent cation [18]. Since lipoprotein e (P4)
does not catalyze the hydrolysis of phosphoserine and requires
divalent copper, assessment of the contribution of the signa-
ture motif of the human enzyme to phosphomonoesterase
activity of e (P4) is unlikely to yield a lipoprotein defective
in enzymatic activity. While the ¢rst and fourth aspartic acid
residues were found to be essential to catalytic activity in e
(P4) and are now thought to participate in catalysis as char-
acterized by Collet et al., the functions of the requisite second
and third aspartic acid residues of the DDDD motif in lipo-
protein e (P4) have yet to be elucidated.
While lipoprotein e (P4)’s role in heme transport has been
reported [5], the mechanism by which this substrate is trans-
located across the outer membrane has yet to be de¢ned. A
mechanism of phosphomonoesterase-dependent heme trans-
port is not supported by these data as two of the four e
(P4) D mutants (D181N and D185A) mediated the transport
of heme as indicated by aerobic growth of E. coli hemA
strains. While presence of residual phosphomonoesterase ac-
tivity in either crude or puri¢ed preparations of the enzyme is
below the level our detection methods cannot be discounted,
the fact that all members of the DDDD superfamily possess
this signature motif suggests that each of the residues is es-
sential for enzymatic activity. As expected, mutation of the
conserved phenylalanine residue, F48, of the heme-binding
site resulted in a mutant protein incapable of heme transport.
Unexpectedly this mutation also abrogated phosphomonoes-
terase activity. Gapped sequence alignment of e (P4) with S.
equisimilis LppC, Streptococcus pyogenes LppA, Flavobacte-
rium meningoseptium OlpA, Helicobacter pylori HP 1285,
and E. coli AphA suggests that the conserved residue at posi-
tion 48 of these phosphatases is leucine [19]. Preliminary re-
sults suggest that mutation of the F48C mutant to C48L with
concomitant loss of the SphI site does not restore e (P4)
phosphomonoesterase activity. Since e (P4) is the only mem-
ber of the group shown to possess a heme-binding site and to
transport heme it may be that presence of this phenylalanine
residue represents an evolutionary compromise for phospho-
monoesterase activity and heme transport.
Initial observations of e (P4)-mediated heme transport in H.
in£uenzae have been recently discounted [6]. New experimen-
tal evidence suggests that observed lack of H. in£uenzae e (P4)
mutants growth under aerobic conditions was a de¢ciency in
NAD uptake and not in heme transport. While relevant with
respect to H. in£uenzae growth in vitro, these mutants were
not point mutations, but produced through random insertion
of transposons leading to disruption of the hel gene [5]. In
addition the NAD concentration required for aerobic growth
of the mutant is 100-fold greater than the minimum required
for aerobic growth of the parent. Irregardless, these observa-
tions fail to explain speci¢c e¡ect of lipoprotein e (P4) on
hemA strains of E. coli when grown in the presence of exog-
enous heme and E. coli hemA strains have no requirement for
NAD. The ability of lipoprotein e (P4) to transport exogenous
heme into E. coli hemA strains appears speci¢c as mutation in
the heme-binding motif resulted in lack of growth under aero-
bic conditions. Incorporation of these D mutants into H. in-
£uenzae and analysis of their e¡ects on in vitro and in vivo
growth are currently in progress.
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